TABLE 2.
Structural determination of β-lactam antibiotics (ampicillin, piperacillin, cefotaxime, ceftazidime, ceftriaxone, cefpodoxime, cefepime, ertapenem, meropenem, and imipenem) and their corresponding hydrolyzed forms, defining the susceptibility and resistance patternsa by MALDI-TOF MSb
Antibiotic | MW (g/mol)c |
Susceptibility pattern (Da) |
Resistance pattern (Da) |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[M + H]+ |
[M + Na]+ |
[M + 2Na]+ |
[M + 3Na]+ |
[M + K]+ |
[M + Na + K]+ |
[M + Cd + H]+ |
[M − X + H]+ |
[M – Xe − CO + H]+ |
[M – X – CO − CO2 + H]+ |
[Mhydrol + H]+ |
[Mhydrol + Na]+ |
[Mhydrol + 2Na]+ |
[Mhydrol + Na + K]+ |
[Mhydrol − CO2 + H]+ |
[Mhydrol − CO2 + Na]+ |
[Mhydrol − CO2 + K]+ |
[Mhydrol − X + H]+ |
[Mhydrol − X − CO2 + H]+ |
|||
Ampicillin | 349.4 | 350.4 | 372.4 | 394.4 | 368.4 | 390.4 | 412.4 | 324.4 | |||||||||||||
Piperacillin | 517.5 | 518.5 | 540.5 | 562.5 | 536.5 | 558.5 | 580.5 | ||||||||||||||
Cefotaxime | 455.5 | 456.5 | 478.5 | 396.5 | 414.5 | 370.5 | |||||||||||||||
Ceftazidime | 546.6 | 547.6 | 468.6 | 486.6 | 442.6 | ||||||||||||||||
Ceftriaxone | 554.6 | 555.6 | 577.6 | 616.6 | 396.6 | 368.6 | 324.6 | 414.6 | 370.6 | ||||||||||||
Cefpodoxime | 427.5 | 428.5 | 450.5 | 473.5 | 466.5 | 414.5 | 370.5 | ||||||||||||||
Cefepime | 480.6 | 481.6 | 296.6 | 414.6 | 370.6 | ||||||||||||||||
Ertapenem | 475.5 | 476.5 | 498.5 | 520.5 | 542.5 | 514.5 | 536.5 | 494.5 | 516.5 | 538.5 | 554.5 | 450.5 | 472.5 | 488.5 | |||||||
Meropenem | 383.4 | 384.5 | 406.5 | 428.5 | |||||||||||||||||
Imipenem | 299.4 | 300.4 | 489.4 |
The terms susceptibility and resistance by MALDI-TOF MS refer to the characteristic mass peak pattern of the antibiotic without modifications and to its corresponding hydrolyzed form. Mhydrol, hydrolysis.
MW, molecular weight.
Imipenem is complexed with the matrix (α-cyano-4-hydroxy-cinnamic acid), resulting in a peak that is the summation of their molecular masses.
X, acetyl for cefotaxime, pyridine for ceftazidime, triazin-ythiol for ceftriaxone, methoxy for cefpodoxime, and pyrrolidine for cefepime.